LEXICON PHARMACEUTICALS, INC. — Proxy Solicitation & Information Statement 2009

Jun 5, 2009

DEFA14A 1 proxy2009.htm PROXY MATERIALS NOTICE CARD proxy2009.htm Licensed to: Lexicon Pharmaceuticals Document Created using EDGARizer 4.0.7.0 Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC. 20549

SCHEDULE 14A

(Rule 14A-101)

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934

Filed by the Registrant x

Filed by a Party other than the Registrant

Check the appropriate box:

| o | Preliminary Proxy Statement | Confidential, for Use of the Commission Only | | --- | --- | --- | | o | Definitive Proxy Statement | (as permitted by Rule 14a-6(e)(2)) | | x | Definitive Additional Materials | | | o | Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12 | |

| LEXICON

PHARMACEUTICALS, INC.
( Name o f Registrant as Specified
In Its Charter)
(Name of
Person(s) Filing Proxy Statement, if Other Than the
Registrant)

Payment of Filing Fee (Check the appropriate box):

x No fee required.

o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

| (1) | Title of each class of securities to which transaction applies: N/A | | --- | --- | | (2) | Aggregate number of securities to which transaction applies: N/A | | (3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): N/A | | (4) | Proposed maximum aggregate value of transaction: N/A | | (5) | Total fee paid: $0 |

| o | Fee paid previously with preliminary materials: N/A | | --- | --- | | o | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |

| (1) | Amount Previously Paid: | | --- | --- | | (2) | Form, Schedule or Registration Statement No.: | | (3) | Filing Party: | | (4) | Date Filed |

| ***

Exercise Your Right to Vote ***
IMPORTANT
NOTICE Regarding the Availability of Proxy
Materials
	Meeting
Information
	Meeting
Type:	Special
Meeting
	For holders
as of:	May 21,
2009
LEXICON
PHARMACEUTICALS, INC.	Date:	July 15,
2009
	Time:	1:30 PM
LST
	Location:	Lexicon
Pharmaceuticals, Inc.
		8800
Technology Forest Place
		The
Woodlands, Texas
	You are
receiving this communication because you hold shares in the above named
company.
LEXICON
PHARMACEUTICALS, INC. 8800
TECHNOLOGY FOREST PLACE THE
WOODLANDS, TX 77381	This is not a
ballot. You cannot use this notice to vote these shares. This
communication presents only an overview of the more complete proxy
materials that are available to you on the Internet. You may view
the proxy materials online at www.proxyvote.com or easily request a paper
copy (see reverse side).
	We encourage
you to access and review all of the important information contained in the
proxy materials before voting.
	See the
reverse side of this notice to obtain proxy materials and voting
instructions.

| *** Before

You Vote ***
How to Access the Proxy
Materials
Proxy
Materials Available to VIEW or RECEIVE:
1.
Notice & Proxy Statement
How
to View Online:
Have the
12-Digit Control Number available (located on the following page) and
visit www.proxyvote.com
How
to Request and Receive a PAPER or E-MAIL Copy:
If you want
to receive a paper or email copy of these documents, you must request
one. There is NO charge for requesting a copy. Please choose
one of the following methods to make your request:
1) BY
INTERNET:	www.proxyvote.com
2) BY
TELEPHONE:	1-800-579-1639
3) BY
E-MAIL*:	sendmaterial@proxyvote.com
*
If requesting materials by e-mail, please send a blank email with the
12-Digit Control Number (located on the following page) in the subject
line
Requests,
instructions and other inquiries sent to this e-mail address will NOT be
forwarded to your investment advisor. Please make the request as
instructed above on or before July 01, 2009 to facilitate timely
delivery.

| *** How

to Vote ***
Please Choose One of the Following Voting
Methods
Vote In Person: Many shareholder
meetings have attendance requirements including, but not limited to, the
possession of an attendance ticket issued by the entity holding the
meeting. Please check the meeting materials for any special
requirements for meeting attendance. At the Meeting you will need to
request a ballot to vote these shares.
Vote by Internet: To vote now by
Internet, go to www.proxyvote.com. Have the 12 Digit Control Number
available and follow the instructions.
Vote by Mail: You can vote by mail
by requesting a paper copy of the materials, which will include a proxy
card.

Voting items

The Board of Directors recommends you vote FOR the following proposal(s)

1. Approval of an amendment to the Company's certificate of incorporation increasing the number of authorized shares of the Company's common stock from 300,000,000 to 900,000,000.

NOTE: In their descretion, upon such other business that may properly come before the meeting or any adjournment or adjournments thereof.

The shares represented by this proxy, when properly executed, will be voted in the manner directed herein by the undersigned Stockholder(s). If no direction is made, this proxy will be voted FOR item 1. If any other matters properly come before the meeting, or if cumulative voting is required, the person named in this proxy will vote in their discretion.